In vitro and in vivo activity of DL-8280, a new oxazine derivative
about
The fluoroquinolones: structures, mechanisms of action and resistance, and spectra of activity in vitroIn vitro and in vivo antibacterial activities of levofloxacin (l-ofloxacin), an optically active ofloxacinMechanistic study of inhibition of levofloxacin absorption by aluminum hydroxideIn vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agentsMechanism of differential activities of ofloxacin enantiomersIn vitro and in vivo antibacterial activity of AM-833, a new quinolone derivativeIn vitro activity of Ro 23-6240, a new fluorinated 4-quinoloneIn vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinoloneAnti-Mycobacterium avium activity of quinolones: in vitro activitiesChemotherapeuticsOfloxacin compared with chloramphenicol in the management of external ocular infectionRecent progress in novel macrolides, quinolones, and 2-pyridones to overcome bacterial resistance.Antibacterial activities and pharmacokinetics of E-4767 and E-5065, two new 8-chlorofluoroquinolones with a 7-azetidin ring substituent.Antimicrobial activity of DU-6859, a new potent fluoroquinolone, against clinical isolates.In vitro antibacterial activity of Q-35, a new fluoroquinoloneInhibition by quinolones of DNA gyrase from Staphylococcus aureus.In vivo evaluation of NM441, a new thiazeto-quinoline derivative.In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.Ofloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.Comparison of the antibacterial in vitro and in vivo activity of ofloxacin (HOE 280 DL 8280) and nalidixic acid analogues.Antibacterial activity of NM394, the active form of prodrug NM441, a new quinolone.E-4695, a new C-7 azetidinyl fluoronaphthyridine with enhanced activity against gram-positive and anaerobic pathogens.Multicenter randomized study of single-dose ofloxacin versus amoxicillin-probenecid for treatment of uncomplicated gonococcal infection.Effect of ofloxacin combined with Lactobacillus casei against Mycobacterium fortuitum infection induced in mice.Comparison of ofloxacin, gentamicin, and tobramycin concentrations in tears and in vitro MICs for 90% of test organisms.Comparative in vitro and in vivo activities of six new monofluoroquinolone and difluoroquinolone 3-carboxylic acids with a 7-azetidin ring substituent.Intraoperative concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue.Purification of Citrobacter freundii DNA gyrase and inhibition by quinolonesActivity of E-3846, a new fluoroquinolone, in vitro and in experimental cystitis and pyelonephritis in rats.Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacinIn vitro and in vivo activities of QA-241, a new tricyclic quinolone derivativeComparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents against Brucella melitensis.Concentrations of ofloxacin in serum and cerebrospinal fluid of patients without meningitis receiving the drug intravenously and orallyStructure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites.Comparative evaluation of enoxacin, ofloxacin, ampicillin, and chloramphenicol for treatment of experimental Haemophilus influenzae pneumonia.In vitro activity of DR-3355, an optically active ofloxacinIn vitro and in vivo antibacterial activities of the fluoroquinolone WIN 49375 (amifloxacin).Activities of new quinoline derivatives against genital pathogens.In vitro activity of CI-934, a quinolone carboxylic acid active against gram-positive and -negative bacteria.In vitro evaluation of A-56619 and A-56620, two new quinolones.
P2860
Q24670241-8EAFC699-868E-4EDB-9AE9-2404645FB7D0Q24671010-25B46668-9C93-46C4-A02A-440EDCBD83B7Q24671290-AB6746ED-A401-442E-90E2-C232BAAB0ABFQ24671799-D164C0A2-69CB-4F10-A0BA-8DD3AA82EED7Q24675769-D7533431-3106-4211-B17B-8108976ADFB9Q24685742-A686E5D6-79F1-4612-8695-8E33FA2A648DQ24685787-0D0DEB71-FA96-4C82-956B-7A56C3829625Q28326997-DB4F0CA7-7782-4821-A8B1-55E5E3A48239Q28378348-B570FB4A-FD3B-4EAA-9CF7-B0DDFAA8FB5BQ30047670-8D44F53A-9711-497A-8D8D-50088145F664Q33649156-F61BA792-1FC3-4C44-BBC2-DE63958576DCQ33771929-574FB61B-B4A9-40D1-B588-97B053BB23C4Q33983352-1C580C55-715A-4E48-B2C2-1F07279A38B4Q34537808-6EEF77C6-92EB-4A7D-908B-63CB8DD92115Q34537973-CD44E8B9-5B6A-4EA2-AA4F-EFCFA379B1B8Q34566027-91A9B7C3-7C26-4A0E-BC2F-4FE5ED53A0CEQ34567225-FA9C496C-DE3B-4571-9487-2BF68071B949Q34681603-FC386464-5D0B-4950-890C-23DDCC43FCAFQ34687048-E4666163-1F89-49EF-8A2B-E10BA3DB5E63Q34707922-BE25E36F-EC20-4E9D-A556-9F626D12461CQ34729788-42D60C90-0BDD-4DF9-B7CB-E6211BE2F933Q35111654-4F043183-7DB6-437A-9902-28C7FCBC30E2Q35244150-C3A12970-F069-42B8-B736-EE443915E069Q35252460-95527C6C-8509-452C-8BC8-749CF60BB3A9Q35270414-3009D129-62F0-46B6-9863-D51ADB4EDE9CQ35284580-4C22A74C-E474-4853-8094-85E08AFED6CFQ35285078-1679DF0E-FED6-4F4A-BAC1-4970CAACE344Q35289324-A5D3E11C-9070-433A-A56E-23CE5D64561FQ35303163-F0272F30-FCEA-4315-91DD-2942DF4F9471Q35319641-D0A81B49-0528-4E67-80D7-304D2828F2BFQ35340351-FAE8CAC4-7586-4D8D-873F-C6CEA5C31644Q35346446-614D5318-FCD5-49E3-89E1-0C965E1605EBQ35353895-AD728516-DA86-4730-9B43-219099FEA20CQ35354313-FA561567-DB61-4F05-B72F-039DBEF09512Q35537723-FDBFF57D-04DB-4558-8E20-764CEB07708EQ35563775-9A3E2707-CB1F-4EBF-9FAF-2593904B6339Q35568734-547E73D2-42E2-44F6-9E00-79230A66812EQ35568919-D224433C-44AD-4C11-8AE9-3BA7BCEB5988Q35647909-6EEA0C53-4DB0-4FDE-A19D-4840410B6D2FQ35648314-D61DAA65-72D9-4099-A0EF-AEE103498D07
P2860
In vitro and in vivo activity of DL-8280, a new oxazine derivative
description
1982 nî lūn-bûn
@nan
1982 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1982 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
name
In vitro and in vivo activity of DL-8280, a new oxazine derivative
@ast
In vitro and in vivo activity of DL-8280, a new oxazine derivative
@en
In vitro and in vivo activity of DL-8280, a new oxazine derivative
@nl
type
label
In vitro and in vivo activity of DL-8280, a new oxazine derivative
@ast
In vitro and in vivo activity of DL-8280, a new oxazine derivative
@en
In vitro and in vivo activity of DL-8280, a new oxazine derivative
@nl
prefLabel
In vitro and in vivo activity of DL-8280, a new oxazine derivative
@ast
In vitro and in vivo activity of DL-8280, a new oxazine derivative
@en
In vitro and in vivo activity of DL-8280, a new oxazine derivative
@nl
P2093
P2860
P356
P1476
In vitro and in vivo activity of DL-8280, a new oxazine derivative
@en
P2093
S Mitsuhashi
Y Matsuura
P2860
P304
P356
10.1128/AAC.22.4.548
P407
P577
1982-10-01T00:00:00Z